“WARNING: DO NOT Hammer on this mechanism” sounds like the start of a side quest. A quest is exactly what [CelGenStudios] started when he came upon a strange box with this message. The military ...

In 1998 I was exposed to the term “disruptive innovation” for the first time. I read a wonderful book, “The Innovator’s Dilemma” by Clayton Christensen, where I learned the difference between ...

Antibody-drug conjugates (ADCs) have reshaped the cancer treatment landscape across a variety of different tumor types. ADCs' peculiar pharmacologic design combines the cytotoxic properties of ...

Drug discovery has long relied on two key strategies: target-based and phenotypic screening. Recombinant technologies and genomics opened the door to modern target-based drug discovery (TBDD), ...